Intralinks Success Stories

We’ve helped clients in nearly every country and industry throughout the world – including more than 99% of the Fortune 1000 – with secure innovative, productivity-driving solutions for high-value M&A, debt capital markets and banking transactions.

Here are just a few of our recent success stories. We’d love to add your brand to our hall of fame.

Express Scripts

US$68.5 billion

Express Scripts
Express Scripts Holding Company, a listed US-based provider of integrated pharmacy benefit management services, used Intralinks for its acquisition by Cigna Corporation for US$68.5 billion.
Aetna

US$77.0 billion

Aetna
Aetna, a listed US-based provider of health insurance products and health care benefits services, used Intralinks for its acquisition by CVS Health Corporation for US$77.0 billion.
LDI Integrated Pharmacy Services

US$605 million

LDI Integrated Pharmacy Services
LDI Integrated Pharmacy Services, a US-based full- service pharmacy benefit manager, used Intralinks for its acquisition by Diplomat Pharmacy from Nautic Partners and Oak HC/FT for US$605 million.

US$2.0 billion

Spectranetics Corporation
Spectranetics Corporation,
a US-based manufacturer and distributor of cardiovascular medical devices, used Intralinks in its acquisition by Koninklijke Philips for US$2.0 billion.

US$1.5 billion

DuPage Medical Group
DuPage Medical Group,
a US multi-speciality physician group, used Intralinks to facilitate an investment of US$1.5 billion by private equity funds managed by Ares Management.

US$5.2 billion

ARIAD Pharmaceuticals, Inc.
ARIAD Pharmaceuticals
used Intralinks in its acquisition by Takeda Pharmaceutical Company for US$5.2 billion.

US$1.1 billion

NeuroDerm
NeuroDerm,
an Israel-based pharmaceutical firm developing next-generation treatments for central nervous system disorders, used Intralinks for its acquisition by Mitsubishi Tanabe Pharma Corporation for US$1.1 billion.

US$1.1 billion

Teva Pharmaceutical Industries
Teva Pharmaceutical Industries,
the Israel-based world leader in generic pharmaceuticals, used Intralinks to divest its PARAGARD® intrauterine device business to CooperSurgical for US$1.1 billion.

€5.7 billion

STADA Arzneimittel
STADA Arzneimittel,
a German, listed pharmaceutical and healthcare company, used Intralinks for its acquisition by Bain Capital and Cinven Partners for €5.7 billion.

US$675 million

Teva Pharmaceutical Industries
Teva Pharmaceutical Industries,
the Israel-based world leader in generic pharmaceuticals, used Intralinks to divest its emergency contraception brands portfolio to Foundation Consumer Healthcare for US$675 million.